Neurobo Pharmaceuticals Inc (NRBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NRBO | AMGN | VRTX | GILD | BMY |
| Company | Neurobo Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 2.35 | 311.82 | 505.42 | 105.16 | 60.23 |
| High | 2.44 | 316.49 | 510.08 | 107.42 | 61.34 |
| Low | 2.32 | 311.16 | 501.07 | 104.92 | 59.84 |
| Last | 2.36 | 316.04 | 503.20 | 107.08 | 61.07 |
| Change | +0.01 | +1.00 | -6.98 | +1.21 | +0.65 |
| % Change | +0.43% | +0.32% | -1.37% | +1.14% | +1.08% |
| Volume | 13,000 | 9,995,000 | 2,280,500 | 26,497,500 | 25,865,500 |
| 20-Day Average Volume | 35,165 | 3,393,335 | 1,374,950 | 10,958,615 | 13,257,561 |
| Previous Close | 2.35 | 315.04 | 510.18 | 105.87 | 60.42 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.50 | 314.78 | 493.70 | 112.62 | 59.87 |
| 20-Day Raw Stochastic | 22.27% | 39.48% | 64.31% | 15.60% | 69.38% |
| 20-Day Relative Strength | 40.86% | 58.97% | 60.40% | 50.17% | 57.43% |
| Weighted Alpha | -57.49 | +13.53 | +21.28 | +53.98 | +25.72 |
| Today's Opinion | 100% Sell | 56% Buy | 72% Buy | 80% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 56% Buy | 56% Buy | 80% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 24% Sell | 24% Buy | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.67% since 11/20/24 | +0.74% since 03/14/25 | -0.31% since 03/14/25 | -3.91% since 03/14/25 | +3.49% since 03/14/25 |
| Low | 2.30 on 11/26/24 | 311.16 on 03/21/25 | 501.07 on 03/21/25 | 104.70 on 03/20/25 | 58.36 on 03/17/25 |
| High | 2.54 on 11/25/24 | 319.31 on 03/18/25 | 517.20 on 03/17/25 | 112.56 on 03/17/25 | 61.34 on 03/21/25 |
| 1-Month | |||||
| %Chg | -15.11% since 10/25/24 | +4.30% since 02/21/25 | +3.92% since 02/21/25 | -2.61% since 02/21/25 | +9.39% since 02/21/25 |
| Low | 2.18 on 11/15/24 | 303.10 on 02/27/25 | 473.51 on 02/27/25 | 104.70 on 03/20/25 | 55.95 on 02/24/25 |
| High | 3.00 on 10/28/24 | 335.88 on 03/10/25 | 519.68 on 03/14/25 | 119.96 on 03/10/25 | 63.33 on 03/11/25 |
| 3-Month | |||||
| %Chg | -31.79% since 08/27/24 | +19.99% since 12/20/24 | +26.66% since 12/20/24 | +15.67% since 12/20/24 | +6.52% since 12/20/24 |
| Low | 2.08 on 10/10/24 | 257.05 on 01/06/25 | 390.92 on 12/23/24 | 88.57 on 01/10/25 | 53.54 on 02/18/25 |
| High | 4.32 on 09/09/24 | 335.88 on 03/10/25 | 519.68 on 03/14/25 | 119.96 on 03/10/25 | 63.33 on 03/11/25 |
| 6-Month | |||||
| %Chg | -42.86% since 05/24/24 | -6.33% since 09/20/24 | +8.23% since 09/20/24 | +27.57% since 09/20/24 | +23.60% since 09/20/24 |
| Low | 2.08 on 10/10/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 81.83 on 09/26/24 | 49.11 on 09/25/24 |
| High | 5.30 on 06/27/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 119.96 on 03/10/25 | 63.33 on 03/11/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,334 | 169,778,272 | 129,216,736 | 133,351,648 | 123,930,080 |
| Shares Outstanding, K | 8,616 | 537,205 | 256,790 | 1,245,346 | 2,029,312 |
| Annual Sales | 0 | 33,424,000,000 | 11,020,100,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -12,470,000 | 4,090,000,000 | -535,600,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 0 | 9,086,000,000 | 2,912,000,000 | 7,569,000,000 | 12,342,000,000 |
| Last Quarter Net Income | -5,650,000 | 627,000,000 | 913,000,000 | 1,783,000,000 | 72,000,000 |
| 60-Month Beta | -0.26 | 0.53 | 0.41 | 0.21 | 0.43 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 11/07/24 | 5.31 on 02/04/25 | 3.98 on 02/10/25 | 1.90 on 02/11/25 | 1.67 on 02/06/25 |
| Latest Earnings Date | 11/11/24 | 05/01/25 | 05/05/25 | 04/24/25 | 04/24/25 |
| Most Recent Dividend | N/A | 2.380 on 02/14/25 | N/A | 0.790 on 03/14/25 | 0.620 on 01/03/25 |
| Next Ex-Dividends Date | N/A | 05/16/25 | N/A | 03/14/25 | 04/04/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.90 | 0.00 | 22.97 | 53.00 |